Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

The U.S. FDA issues five observations to Glenmark Pharma’s North Carolina manufacturing facility.

by Team Small News | Jun 19, 2025 | Glenmark, Pharma

The U.S. Food and Drug Administration (FDA) recently conducted a Good Manufacturing Practice (GMP) inspection of Glenmark Pharmaceuticals’ manufacturing facility in Monroe, North Carolina. The inspection, which took place from June 9-17, resulted in the FDA...

Glenmark Pharma’s Chairman and Managing Director emphasized the importance of maintaining concentration and undertaking initiatives that are on par with global standards.

by Team Small News | Jun 18, 2025 | Glenmark, Pharma

Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals Ltd, reflects on the company’s over two-decade journey, highlighting the challenges of transitioning from a generic-focused business to a more innovative space. Saldanha notes that this...

Glenmark introduces Zanubrutinib, a novel cancer treatment, to the Indian market

by Team Small News | Jun 11, 2025 | Glenmark, Pharma

Glenmark Pharmaceuticals, a renowned drug company, has announced its plan to launch a cancer treatment drug called zanubrutinib, also known as Brukinsa, in India. The drug has been approved by the Drugs Controller General of India (DCGI) and will be used to treat five...

Glenmark says the FDA may reinspect its Monroe site at any moment.

by Team Small News | Jun 6, 2025 | Glenmark, Pharma

Glenmark, an Indian pharmaceutical company, recently reported its earnings for the 2025 financial year. While the company’s overall performance was affected by a weak second half in its India business, it is planning to revive growth in both its core markets:...

Glenmark Pharmaceuticals’ (NSE:GLENMARK) financial results appear less impressive upon closer examination.

by Team Small News | Jun 2, 2025 | Glenmark, Pharma

Glenmark Pharmaceuticals’ latest earnings report may appear impressive at first glance, but a closer examination reveals some underlying weaknesses. The company’s net profit increased by 15.6% year-over-year, reaching ₹2.16 billion, and revenue grew by...

Glenmark Pharmaceuticals Sees Significant Profit Increase in March 2025 Despite Elevated Interest Expenses – MarketsMojo

by Team Small News | May 24, 2025 | Glenmark, Pharma

Glenmark Pharmaceuticals has announced its financial results for the fourth quarter and full year ended March 2025, highlighting a solid profit growth despite increasing interest costs. The company’s performance was driven by robust sales across its key markets...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress